Exencial Wealth Advisors, LLC Astrazeneca PLC Transaction History
Exencial Wealth Advisors, LLC
- $2.63 Billion
- Q1 2025
A detailed history of Exencial Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 31,053 shares of AZN stock, worth $2.14 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
31,053
Previous 24,168
28.49%
Holding current value
$2.14 Million
Previous $1.58 Million
44.16%
% of portfolio
0.09%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,426Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.93 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.8 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.45 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.19 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.15 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $213B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...